Everything Lupus: Resource Hub

Default Image

Quebec pharmacists to begin

Read
Default Image

COVID-19 Resource Document

Read
Default Image

COVID-19 Prevention and Risks

Read
Default Image

Left Behind: Immunocompromised Canadians Living in the Shadow of COVID-19

Read
Default Image

The Canadian Immunocompromised Advocacy Network (CIAN) – Advocating for immunocompromised people across Canada

Read
Default Image

Using CyTOF to dissect the interplay between Type I interferon and autoantibody production in Systemic Lupus Erythematosus

Read
Default Image

Now Enrolling People with Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) For A Research Study.

Read
Default Image

COVID-19 VACCINE ROLLOUT

Read
Default Image

AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis

Read
Default Image

Dr. Samir Gupta explains how the four COVID-19 vaccines now approved in Canada work and why efficacy rates aren’t the most important number to look at.

Read
Default Image

Six Bio-Ethicists on Ontario Government’s “Bioethics Table” Confirm Ongoing Concerns Raised by Disability Organizations regarding the Discriminatory and Secret Plans for the Triaging of Critical Care

Read
Default Image

LUPUS AND COVID-19 VACCINATION WAIT TIMES

Read